BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
NEUROG3
,
G-protein-coupled receptor binding
,
Inflammatory disorder
,
Lung
,
Rapamycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NK T cell activation
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Monocyte of peripheral blood
Myeloid cells of peripheral blood
Ileum mucosa
Colon mucosa
B lymphocyte (IgM memory) of spleen
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Contact dermatitis
Encephalomyelitis
Vesicular stomatitis Indiana virus disease
Bacterial infection due to Bacillus
Protozoan infection
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Antiviral Agents
sulfathiazole
pyridine
Tin Fluorides
MLN4924
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR128-1
TERF2IP
CHMP2A
MUTYH
PRAF2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
L1000 CMAP - Embryonic kidney 293T cells with shRNA-mediated gene knockdown
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies
Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I
Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas
Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplast…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ